Orexo AB Provides US Commercialization Progress Update and Direction for 2013 Financial Outlook

Published: Dec 19, 2012

Orexo AB (Orexo) today informs about the progress towards becoming a full -fledged specialty pharmaceutical company with a US commercial presence. Orexo also announced the company project it will turn profitable in late 2013, with the current assumptions on regulatory timing and launch of Zubsolv™ in September 2013.

Back to news